Related Experiment Videos
Chorionic biopsy in management of severe Kell alloimmunization.
American Journal of Obstetrics and Gynecology
|January 1, 1987
Summary
Fetal Kell antigen can be determined from fetal red blood cells as early as 10 weeks gestation via chorionic biopsy. This early detection aids in managing severe Kell-hemolytic disease.
Area of Science:
- Obstetrics and Gynecology
- Fetal Medicine
- Immunology
Background:
- Kell-hemolytic disease of the fetus and newborn (HDFN) is a serious condition.
- Accurate and timely diagnosis is crucial for effective management.
- Current diagnostic methods may have limitations in early gestation.
Observation:
- Fetal red blood cells can be reliably obtained via chorionic villus sampling (CVS) at 10 weeks gestation.
- Kell antigen expression is detectable on these fetal red blood cells.
Findings:
- The study demonstrates the feasibility of determining fetal Kell antigen status using fetal red blood cells obtained at 10 weeks gestation.
- This method provides an early opportunity for identifying fetuses at risk for Kell-HDFN.
Implications:
- Early identification of Kell antigen status can guide prenatal management strategies.
- This may lead to improved outcomes for pregnancies affected by Kell-HDFN.
- Facilitates timely interventions to prevent or mitigate fetal anemia and hydrops fetalis.